Table 1 Characteristics of healthy individuals and VPA-Patients
From: Ex vivo radiosensitivity is increased in non-cancer patients taking valproate
| Â | Healthy Individuals | Patients | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Variable | n | mean | SD | min | max | n | mean | SD | min | max |
Age (years) | 62 | 46.4 | 17.4 | 21 | 84 | 31 | 46.4 | 17.5 | 21 | 84 |
Sex (% female) | 62 | 56.9 | – |  |  | 31 | 38.7 | – | – | – |
Dosage per day (mg) | – | – | – | – | – | 31 | 1708 | 637.1 | 900 | 3000 |
Height (cm) | – | – | – | – | – | 18 | 175.7 | 10.1 | 158 | 190 |
Weight (kg) | – | – | – | – | – | 27 | 83.4 | 17.9 | 50 | 126 |
Trough plasma level (mg/l) | – | – | – | – | – | 27 | 65.5 | 20.0 | 24.6 | 99.8 |
Plasma level at time of blood draw (mg/l) | – | – | – | – | – | 29 | 64.8 | 21.6 | 20.0 | 108.0 |
Epilepsy (%) | – | – | – | – | – | 31 | 90.0 | – | – | – |
Comedication | – | – | – | – | – | 31 | 3.7 | 3.0 | 0 | 0 |